886 In vitro study of the effects of ceralasertib (AZD6738) on the tumor microenvironment cell populations

Ítems similars

• 886 In vitro study of the effects of ceralasertib (AZD6738) on the tumor microenvironment cell populations
  per: Gemma Jones, et al.
  Publicat: (2023-11-01)
• The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy
  per: Frank P. Vendetti, et al.
  Publicat: (2023-02-01)
• Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment‐Resistant Cancer Cells
  per: Francis M. Barnieh, et al.
  Publicat: (2024-09-01)
• ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
  per: Hui Wang, et al.
  Publicat: (2020-05-01)
• An orally available cancer drug AZD6738 prevents type 1 diabetes
  per: Norie Sugitani, et al.
  Publicat: (2023-12-01)